Evidence map›Paper›PMID 36737552›Full record

ArticleArchives of gynecology and obstetrics2023

Management of patients with advanced epithelial ovarian cancer: a European survey.

Floriane Jochum, Martina Aida Angeles, Vincent Balaya, Leonor Drouin, Tanja Nikolova, Patrice Mathevet, Fabrice Lécuru, Henri Azais, Sarah Betrian, Pierre-Adrien Bolze and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of gynecology and obstetrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Floriane JochumDepartment of Obstetrics and Gynecology, University Hospital, Strasbourg, France. jochum.floriane@gmail.com.ORCID http://orcid.org/0000-0001-5009-3936
Martina Aida AngelesDepartment of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT), Oncopole, Toulouse, France.
Vincent BalayaDepartment of Obstetrics and Gynecology, Foch Hospital, Suresnes, France.
Leonor DrouinDepartment of Gynecology, CHU de Limoges, Limoges, France.
Tanja NikolovaAcademic Teaching Hospital of Heidelberg University, Baden-Baden, Germany.
Patrice MathevetWomen-Mother-Child Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Fabrice LécuruBreast, Gynecology and Reconstructive Surgery Unit, Curie Institute, Paris, France.
Henri AzaisGynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, Paris, France.
Sarah BetrianDepartment of Medical Oncology, IUCT Oncopole, Toulouse, France.
Pierre-Adrien BolzeDepartment of Gynecology, CHU Lyon Sud, Pierre-Bénite, France.
Yohann DabiDepartment of Gynecology, Tenon Hospital, AP-HP, Paris, France.
Yohan KerbageDepartment of Gynecology, Jeanne de Flandre Hospital, Lille, France.
Claire SansonSurgical Oncology Department, Gustave Roussy Institute, Villejuif, France.
François ZaccariniSurgical Oncology Department, Gustave Roussy Institute, Villejuif, France.
Fréderic GuyonSurgical Oncology Department, Bergonié Institute, Bordeaux, France.
Cherif AkladiosDepartment of Obstetrics and Gynecology, University Hospital, Strasbourg, France.
Arthur HsuDepartment of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
Sofiane BendifallahDepartment of Gynecology, Tenon Hospital, AP-HP, Paris, France.
Elise DelucheOncology Department, University Hospital, Limoges, France.
Benedetta GuaniDepartment of Obstetrics and Gynecology, Fribourg Hospital, Fribourg, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to assess current European practices in the management of patients with advanced epithelial ovarian cancer in 2021.

methodsA 58-question electronic survey was distributed anonymously to the members of six European learned societies. Initial diagnostic workup and staging, pathological data, surgical data, treatments and follow-up strategies were assessed.

resultsA total of 171 participants from 17 European countries responded to emailed surveys. Most participants were experienced practitioners (superior than 15 years of experience) specializing in gynecology-obstetrics (29.8%), surgical oncology (25.1%), and oncogynecology (21.6%). According to most (64.8%) participants, less than 50% of patients were eligible for primary debulking surgery. Variations in the rate of primary debulking surgery depending on the country of origin of the practitioners were observed in this study. The LION study criteria were applied in 70.4% of cases during PDS and 27.1% after chemotherapy. In cases of BRCA1-2 mutations, olaparib was given by 75.0-84.8% of respondents, whereas niraparib was given in cases of BRCA wild-type diseases.

conclusionsThis study sheds light on current practices and attitudes regarding the management of patients with advanced epithelial ovarian cancer in Europe in 2021.

Indexed as

Ovarian NeoplasmsCarcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresEuropeFemaleHumansNeoadjuvant TherapyNeoplasm StagingSurveys and QuestionnairesDisparities, guidelinesEuropean surveyOvarian cancer

Identifiers

PMID36737552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.